» Articles » PMID: 36243748

Novel Lipid Indicators and the Risk of Type 2 Diabetes Mellitus Among Chinese Hypertensive Patients: Findings from the Guangzhou Heart Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Data are limited on whether several easily measured indices are independent predictors of type 2 diabetes mellitus (T2DM) in hypertensive patients. This study aimed to assess the association of hypertriglyceridemic-waist phenotype, triglyceride glucose (TyG) index, lipid accumulation product (LAP), and visceral adiposity index (VAI) with T2DM risk in hypertensive patients.

Methods: This cross-sectional study included 5321 hypertensive patients from the baseline survey of the Guangzhou Heart Study. Face-to-face questionnaire survey, physical examination, and fasting blood sample collection were completed for all subjects. Odds ratio (OR) with 95% confidence interval (95% CI) were calculated by using the logistic regression model. The potential nonlinear relationship was examined using restricted cubic spline regression.

Results: The prevalence of T2DM was 19.98% among hypertensive patients. After adjusting for confounders, participants with elevated triglyceride levels and enlarged waist circumference (HTGW) were associated with a 2.57-fold risk of T2DM (OR 2.57, 95% CI 2.05, 3.23). When comparing with subjects within the lowest quartile of the indices, those in the highest quartile of TyG, LAP, and VAI were associated with 5.35-fold (95% CI 4.33, 6.64), 2.65-fold (95% CI 2.11, 3.34), and 2.17-fold (95% CI 1.77, 2.67) risk of T2DM after adjusting for confounders. Every 1-unit increment of TyG, LAP, and VAI was associated with 81%, 38%, and 31% increased risk of T2DM, respectively. The nonlinear association was observed for TyG, LAP, and VAI (all P  < 0.001).

Conclusions: The results found that among hypertensive patients, HTGW and a higher level of TyG, LAP, and VAI were associated with an elevated risk of T2DM. The findings suggested that HTGW, TyG, LAP, and VAI may serve as simple and effective tools for T2DM risk assessment in the prevention and management of main chronic diseases.

Citing Articles

Clinical significance of Ki-67 in patients with lung adenocarcinoma complicated by type 2 diabetes.

Chen K, Wang G, Hu J, Zhou Y, Ma H World J Diabetes. 2025; 16(2):98423.

PMID: 39959263 PMC: 11718486. DOI: 10.4239/wjd.v16.i2.98423.


Triglyceride-glucose index predicts adverse cardiovascular events in patients with H-type hypertension combined with coronary heart disease: a retrospective cohort study.

Li C, Zhao S, Li Y, He S, Jian W, Liu Y Cardiovasc Diabetol. 2025; 24(1):45.

PMID: 39881304 PMC: 11780827. DOI: 10.1186/s12933-024-02555-x.


Perspective from NHANES data: synergistic effects of visceral adiposity index and lipid accumulation products on diabetes risk.

He J, Chen L Sci Rep. 2025; 15(1):258.

PMID: 39747273 PMC: 11696142. DOI: 10.1038/s41598-024-84034-7.


The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes.

Gounden V, Devaraj S, Jialal I Lipids Health Dis. 2024; 23(1):416.

PMID: 39716258 PMC: 11664894. DOI: 10.1186/s12944-024-02412-6.


Elevated metabolic score for visceral fat was associated with increased prevalence of gallstones in American adults: a cross-sectional study.

Lin H, Shi K, Luo S, Ye W, Cai X Front Med (Lausanne). 2024; 11:1474368.

PMID: 39574912 PMC: 11578707. DOI: 10.3389/fmed.2024.1474368.